Cogent Biosciences, Inc.
COGT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001622229
In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Cogent Biosciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 135 | 3 | 144 | +12 |
| Shares | 90.9M | 164.9K | 90.8M | +118.8K (+0.1%) |
| Value | $885.8M | $1.60M | $534.0M | −$350.2M (−39.6%) |
3 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (36)
Institutions that held Cogent Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (24)
Institutions that held Cogent Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Ra Capital Management, L.P. | 6,416,147 | $62.6M |
| Baker Bros. Advisors LP | 1,292,966 | $12.6M |
| Adage Capital Partners GP, L.L.C. | 1,036,069 | $10.1M |
| Cormorant Asset Management, LP | 1,000,000 | $9.75M |
| Walleye Capital LLC | 552,908 | $5.39M |
| Boxer Capital, LLC | 525,000 | $5.12M |
| Altium Capital Management LP | 235,000 | $2.29M |
| Paradigm Biocapital Advisors LP | 225,605 | $2.20M |
| Balyasny Asset Management LLC | 125,638 | $1.22M |
| DekaBank Deutsche Girozentrale | 85,000 | $833.0K |
| Ikarian Capital, LLC | 62,766 | $612.0K |
| Walleye Trading LLC | 38,652 | $376.9K |
| Wexford Capital LP | 30,000 | $292.5K |
| Prelude Capital Management, LLC | 27,100 | $264.2K |
| PEAK6 Investments LLC | 23,224 | $226.4K |
| Values First Advisors, Inc. | 10,318 | $100.6K |
| Fox Run Management, L.L.C. | 10,111 | $98.6K |
| Simplex Trading, LLC | 2,629 | $25.0K |
| Lindbrook Capital, LLC | 271 | $2.64K |
| US Bancorp | 245 | $2.39K |
| Newbridge Financial Services Group, Inc. | 122 | $1.19K |
| Baker Avenue Asset Management, LP | 21 | $205 |
| Advisor Group Holdings, Inc. | 17 | $166 |
| Allworth Financial LP | 12 | $117 |
Not filed for Q4 2023 yet (3)
Institutions that held Cogent Biosciences, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| International Biotechnology Trust PLC | 135,000 | $1.31M |
| Pathstone Family Office, LLC | 17,309 | $168.8K |
| Innovis Asset Management LLC | 12,551 | $122.4K |